EUS-guided cytologic diagnosis of pancreatic endocrine tumors: Immunocytochemical features and the impact of on-site cytopathological assessment

MLA

F Brizzi, et al. “EUS-Guided Cytologic Diagnosis of Pancreatic Endocrine Tumors: Immunocytochemical Features and the Impact of on-Site Cytopathological Assessment.” Endoscopy, vol. 43, Nov. 2011. EBSCOhost, https://doi.org/10.1055/s-0031-1292093.

APA

F Brizzi, D. Reggio, Lavinia Mezzabotta, Antonella Barreca, M. Goss, Donatella Pacchioni, Giovanni Bussolati, Patrizia Carucci, M. Rizzetto, Mauro Bruno, C. De Angelis, & P. Allegranza. (2011). EUS-guided cytologic diagnosis of pancreatic endocrine tumors: Immunocytochemical features and the impact of on-site cytopathological assessment. Endoscopy, 43. https://doi.org/10.1055/s-0031-1292093

Chicago

F Brizzi, D. Reggio, Lavinia Mezzabotta, Antonella Barreca, M. Goss, Donatella Pacchioni, Giovanni Bussolati, et al. 2011. “EUS-Guided Cytologic Diagnosis of Pancreatic Endocrine Tumors: Immunocytochemical Features and the Impact of on-Site Cytopathological Assessment.” Endoscopy 43 (November). doi:10.1055/s-0031-1292093.